SECTRA (SECT) Q4 24/25 earnings summary
Event summary combining transcript, slides, and related documents.
Q4 24/25 earnings summary
11 Nov, 2025Executive summary
Achieved record contracted order intake of SEK 8.7 billion, with a book-to-bill ratio of 2.7, driven by large contracts in North America and other markets.
Net sales for the fiscal year reached SEK 3.24 billion, up 9.3% year-over-year, with recurring revenue up 19.9% and cloud recurring revenue up 48.9%.
Transition to service-based and cloud-based (SaaS) models advanced, increasing recurring revenue share to 70% and impacting revenue recognition.
Profit per share increased by 32% to SEK 2.92, supported by a one-time patent settlement of SEK 110 million.
Proposed ordinary and extraordinary dividends, reflecting robust cash flow and financial position.
Financial highlights
Contracted order bookings rose 39.9% to SEK 8,706.1 million; guaranteed order bookings up 137.7%.
Operating profit, excluding the patent settlement, rose 18% year-over-year to SEK 613 million; Q4 operating profit was SEK 199 million.
Operating profit margin improved to 18.9% due to higher gross margin and controlled operating expenses.
Cash flow from operations was strong at SEK 922 million for the year, with SEK 222 million in Q4.
Earnings per share reached SEK 2.92, and cash flow per share was SEK 4.79.
Outlook and guidance
Currency headwinds expected to impact sales and profitability in the coming year due to a stronger Swedish krona and exposure to USD, EUR, and GBP.
Highest priority is accelerating customer onboarding to realize revenue from the large order backlog.
SaaS and cloud transition expected to continue for another 1–2 years, with recurring revenue and cloud sales as key growth drivers.
Major customers going live may temporarily pressure profitability before full revenue realization.
Long-term demand for medical IT and cybersecurity expected to remain strong due to demographic and digitalization trends.
Latest events from SECTRA
- Cloud recurring revenue surged 58% and operating profit rose 21%, led by Imaging IT growth.SECT
Q3 25/266 Mar 2026 - Cloud recurring revenue surged 55.9% and operating profit rose 13.6% year-over-year.SECT
Q4 23/2431 Jan 2026 - Q1 sales up 24%, operating profit up 44%, with strong recurring and cloud revenue growth.SECT
Q1 24/2522 Jan 2026 - Record order intake and recurring revenue growth offset by lower profit during cloud transition.SECT
Q2 24/2511 Jan 2026 - Sales up 13%, cloud recurring revenue up 44%, and profit boosted by a patent settlement.SECT
Q3 24/2521 Dec 2025 - Cloud and recurring revenue growth drive profit, but upfront costs pressure margins.SECT
Q2 25/2612 Dec 2025 - SaaS, AI, and integrated diagnostics drive global growth and leadership in medical IT.SECT
CMD 20251 Dec 2025 - Order bookings and recurring revenue surged, driven by SaaS and US/Canada growth.SECT
Q1 25/264 Sep 2025